Marcos Borato Viana

Marcos Borato Viana

Auto-generated profile, based on publicly available information

Marcos Borato Viana

Faculdade de Medicina/NUPAD, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2009 in Leukemia
Verified
Journal Article
Closed access
PDF file
PJP Y Jotta
P Y Jotta
MGM A Ganazza
M A Ganazza
ASA Silva
A Silva
MVM B Viana
M B Viana
MSM J da Silva
M J da Silva
JYJosé Andrés Yunes
José Andrés Yunes

1 May 2005 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
MMM. Murao
M. Murao
MVM.B. Viana
M.B. Viana
Blood transfusion in patients with sickle cell disease (SCD) is limited by the development of alloantibodies to erythrocytes. In the present study, the frequency and risk factors for alloimmunization were determined. Transfusion records and medical charts of 828 SCD patients who had been transfused and followed at the Belo Horizonte Blood Center, Belo Horizonte, MG, Brazil, were retrospectively reviewed. Alloimmunization frequency was 9.9% (95% CI: 7.9 to 11.9%) and 125 alloantibodies were detected, 79% of which belonged to the Rhesus and Kell systems. Female patients developed alloimmunization more frequently (P = 0.03). The median age of the alloimmunized group was 23.3 years, compared to 14.6 years for the non-alloimmunized group (P < 0.0001). Multivariate analyses were applied to the data for 608 hemoglobin (Hb) SS or SC patients whose number of transfusions was recorded accurately. Number of transfusions (P = 0.00006), older age (P = 0.056) and Hb SC (P = 0.02) showed independent statistical associations with alloimmunization. Hb SC patients older than 14 years faced a 2.8-fold higher (95% CI: 1.3 to 6.0) risk of alloimmunization than Hb SS patients. Female Hb SC patients had the highest risk of developing alloantibodies. In patients younger than 14 years, only the number of transfusions was significant. We conclude that an increased risk of alloimmunization was associated with older patients with Hb SC, specially females, even after adjustments were made for the number of transfusions received, the most significant variable.

22 March 1994 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
GRG. Rindi
G. Rindi
CPC. Patrini
C. Patrini
Umberto LaforenzaUmberto Laforenza
Umberto Laforenza
HMH. Mandel
H. Mandel
MBM. Berant
M. Berant
AZA. N. F. Zarra
A. N. F. Zarra

15 November 2010 in Hemoglobin
Verified
Journal Article
Closed access
PDF file
ABAndré Rolim Belisário
André Rolim Belisário
CRCibele Velloso Rodrigues
Cibele Velloso Rodrigues
MMMarina Lobato Martins
Marina Lobato Martins
CSCélia Maria Silva
Célia Maria Silva
MVMarcos Borato Viana
Marcos Borato Viana
The study estimated α-thalassemia (α-thal) prevalence and assessed its associations with clinical and hematological features in a random sample of Brazilian children with sickle cell anemia (208 Hb SS and 13 Hb S-β0-thal). α-Thalassemia genotyping was carried out by multiplex polymerase chain reaction (m-PCR) for seven alleles. Clinical and hematological data were retrieved from the 221 children's medical files. Their ages ranged from 2.5 to 10.4 years. Of the Hb SS children, 27.9% carried –α3.7/αα and 1.4% –α3.7/–α3.7. The presence of α-thal was significantly associated with reduction in MCV, MCH, WBC values and reticulocyte counts. No significant association with blood transfusion or acute chest syndrome (ACS), was found. α-Thalassemia genotypes were strongly associated with reduction in risk for cerebrovascular disease (CVD) (conditional and abnormal transcranial Doppler or stroke; p = 0.007). The interaction of α-thal with other modulating factors should be investigated in order to define subphenotypes of the disease and to use them as clinical tools in the follow-up care of patients.

1 August 1978 in The Journal of Pediatrics
Verified
Journal Article
Closed access
MVMarcos Borato Viana
Marcos Borato Viana
RCRomeu Ibrahim Carvalho
Romeu Ibrahim Carvalho

1 March 1980 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
MVMarcos B. Viana
Marcos B. Viana
HMHelen S. Maurer
Helen S. Maurer
CFChristine Ferenc
Christine Ferenc